Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD

Size: px
Start display at page:

Download "Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD"

Transcription

1 Cannabidiol as a potential treatment for anxiety disorders Esther Blessing, MD PhD

2 Overview History and of cannabidiol (CBD) and cannabis Safety and tolerability of CBD CBD pharmacology Clinical need for anxiolytic drugs Evidence for CBD as an anxiolytic Current clinical research with CBD and cannabinoid related drugs

3 What is cannabidiol? CBD is one of ~ 100 cannabinoid compounds unique to Cannabis plants CBD does not produce psychoactive effects like 9- THC, the other main cannabinoid Cannabinoids produced by trichome glands in hairs of buds on female Cannabis plants Female plants Flower buds Trichome glands Dried bud

4 Cannabis Commonly used psychoactive substance worldwide Multiple varieties varying in cannabinoid composition C. Indica C. Sativa Used for fiber Sedative CBD:THC ratio Strong high THC:CBD ratio Increasing legalization and medical use

5 History of medicinal cannabis use (1) ~ 8,000 BCE use in China as rope, later used for garments, paper, and medicine 2700 BCE Used in ancient Egypt, India, Africa, Greece, Rome and Arab world to treat multiple ailments Marijuana Tax Act- prohibited use, AMA opposed delta-9-tetrahydrocannabinol (THC) isolated by Raphael Mechoulam THC determined to be drug with no accepted use Randell gets IND to treat glaucoma in court battle

6 History of medicinal cannabis use (2) s Small randomized clinical trials for treating epilepsy s Human and animal experimental trials show low-dose THC is anxiolytic, high dose is anxiogenic and pro-psychotic Synthetic THC (eg marinol and cesamet) approved by FDA for treatment of cancer associated nausea, pain, loss of appetite 1996 CB1 receptor cloned, endocannabinoid system discovered

7 History of medicinal cannabis use (2) California legalizes Cannabis for AIDS, cancer treatment 2000s Role of the endocannabinoid system in emotional brain discovered, explosion in cannabinoid research 2010s Sativex: 50/50 THC/CBD oral spray approved for spasticity in MS in the UK 2015 Completion of Phase II trials for Epidiolex: pure CBD oral for treatment of childhood epilepsy in the US

8 Cannabidiol Plant-derived Cannabinoids ~ 100 different types in Cannabis Cannabinol Cannabigerol Tetrahydrocannabivarin Cannabichromene Izzo et al, Cell, 2009 Fo Δ 9 Tetrahydro cannabinol

9 Endocannabinoids (ecbs) (Endogenous activators of the cannabinoid receptor) ecbs: Anandamide & 2-AG Enzymes FAAH and MGL CB1 and CB2 receptors receptor Other receptors, eg TRP receptors DiMarzo 2004

10 The Cannabinoid receptors (Endogenous activators of the cannabinoid receptor)

11 Endocannabinoids (ecbs) (Endogenous activators of the cannabinoid receptor) ecbs synthesized from cell lipids in response to strong neuronal activity ecbs activate the CB1 receptor and other receptors on presynaptic GABA and glutamate neurons, leads to neurotransmitter inhibition Brain-wide and in periphery Roles in appetite, inflammation, emotion, nociception, etc

12 Endocannabinoids currently an anxiolytic drug target

13 Increasing interest in cannabidiol CBD characterized in 1963 by Raphael Mechoulam

14 Multiple clinical uses for CBD Anxiolytic / sedative s initial acute dosing studies in rat and human show anxiolytic effects, reversing effects of THC (Zuardi et al) Anti-epileptic controlled clinical trials with CBD in epilepsy, 2015 Orin Devinsky, NYU Langone, JAMA neurology, Epidiolex (pure CBD) reduces seizures in Dravet-syndrome Anti-inflammatory, anti-emetic, antineoplastic, neuroprotective, anti-diabetic Devinsky et al, Epilepsia, 2014 Campos et al, Phil Trans Lon, 2012

15 Overview Safety and tolerability of CBD CBD pharmacology Clinical need for anxiolytic drugs Evidence for CBD as an anxiolytic Current clinical research with CBD and cannabinoid related drugs

16 Safety and tolerability of CBD Well tolerated across a wide dose range, up to 1500 mg/day oral no reported psychomotor slowing, negative mood effects, or vital sign abnormalities, although some mild sedative effects (Bergamaschi, 2011). Pediatric phase III trials completed, (Devinsky et al, 2015) Drug-drug interactions: potent inhibitor of P450 isozymes, primarily CYP2C and CYP3A classes may potentiate THC effects when given in combination

17 CBD pharmacology (1) *Indirect effects Campos et al, 2012; McPartland et al, 2015; Ibeas et al, 2015

18 CBD pharmacology (2) Complicated! ~ 65 targets, mostly enzymes Not clear whether in vitro receptor data represents physiological in vivo effects Disputed whether CBD acts on the endocannabinioid system Many targets remain uncharacterized McPartland et al, 2015; Ibeas et al, 2015

19 Overview Clinical need for anxiolytic drugs Evidence for CBD as an anxiolytic Current clinical research with CBD and cannabinoid related drugs

20 Anxiety disorders overview Combined US lifetime prevalence of 29 %, highest of any mental disorder, immense social and economic burden DSM-4 Trauma DSM5

21 Current anxiolytic medications Serotonin reuptake inhibitors; serotonin norepinephrine DSM-4 reuptake inhibitors; benzodiazepines; MAO inhibitors; tricyclic antidepressant drugs; partial 5-hydroxytryptamine (5-HT) 1A receptor agonists Anticonvulsants and atypical antipsychotics also used to treat PTSD Associated with limited response rates and residual symptoms, particularly in PTSD Adverse effects limit tolerability and adherence

22 Barriers to drug development 3-12 billion to the development of new agents, including failure costs Unclear pipelines: preclinical anxiety tests lack not only predictive validity (the ability to predict new drugs) but also postdictive validity (sensitivity to existing drugs). Forbes.com: The truly staggering cost of investing new drugs

23 Overview Evidence for CBD as an anxiolytic Current clinical research with CBD and cannabinoid related drugs

24 Converging evidence for CBD as an anxiolytic 1. Epidemiologic 2. Preclinical (animal model) evidence 3. Role for endocannabinoids in anxiety 4. Human experimental data Cannabidiol as a Potential Treatment for Anxiety Disorders Blessing EM, Steenkamp MM, Manzanares J, Marmar CR Neurotherapeutics, 2015

25 Epidemiological evidence Limited: Reports marijuana with higher CBD:THC ratio reduces risk of psychosis (Manseau et al, 2015; Iseger et al, 2015) Anecdotal evidence that smoking marijuana reduces anxiety, but anxiogenic effects also reported, complex causal interactions possible, requires further controlled studies also not specific for CBD

26 Preclinical evidence Strong: CBD reduces multiple anxiety behaviors in over 50 studies, including both unconditioned and conditioned behaviors Suggests potential for treating PTSD, GAD and PD However: U-shaped dose curve evident (maybe due to TRP channel activation), also different effective doses in different paradigms. Chronic data lacking.

27 Human experimental evidence (1) Strong psychological data: Multiple studies: CBD ( mg) reduces anxiety associated with public speaking, imaging procedure anxiety and THC ingestion in normal and SAD subjects (Zuardi) CBD may enhance extinction of conditioned fear (Das 2012) However: No dose finding studies published

28 Human experimental evidence (2) Moderate neuroimaging evidence Several small sample functional imaging studies suggest oral CBD ( mg) reduces activation in the amygdala and other brain areas associated with anxiety (Fusar-Poli et al)

29 CBD as an anxiolytic: evidence summary Moderate-strong preclinical and acute human experimental evidence to suggest broad anxiolytic effects Chronic dosing studies in clinical populations needed Unknown what the most effective anxiolytic dose, dose-finding studies needed

30 Overview Current clinical research issues with CBD and cannabinoid related drugs

31 Current landscape for CBD and anxiety Chronic dosing with dose-finding studies in clinical populations needed Stigma associated with CBD originating from a schedule I drug persist Limited sources of pure with Phase I safety data available likely to increase with changing legal landscape Stay tuned!!

Research on Cannabis and PD: Is there any evidence?

Research on Cannabis and PD: Is there any evidence? Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES

More information

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section Disclosures Site principal investigator of studies of cannabidiol(epidiolex) in the treatment of

More information

Medical Cannabis MATT WEBSTER DO, MS

Medical Cannabis MATT WEBSTER DO, MS Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use

More information

The Scientific Side of Medical Marijuana

The Scientific Side of Medical Marijuana The Scientific Side of Medical Marijuana Ken Mackie, MD Indiana University Bloomington, IN December 3, 2009 kmackie@indiana.edu Financial disclosures NIH (NIDA) - research grants Alzheimer s Association

More information

Federal Law: Marijuana

Federal Law: Marijuana Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not

More information

Cannabidiols & Epilepsy. Orrin Devinsky, M.D. Department of Neurology NYU Langone School of Medicine

Cannabidiols & Epilepsy. Orrin Devinsky, M.D. Department of Neurology NYU Langone School of Medicine Cannabidiols & Epilepsy Orrin Devinsky, M.D. Department of Neurology NYU Langone School of Medicine Cannibas in History Cannibas sativa? ~8,000 bce in China - rope Cultivated, used for garments, bowstrings,

More information

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility. Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound

More information

CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY

CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY NOEL ROBERT WILLIAMS MD FACOG DIRECTOR OPTIMAL HEALTH ASSOCIATES OKLAHOMA CITY, OKLAHOMA How Did We Get Here? In November 2012 Tikun Olam,

More information

The Return of Medicinal Cannabis

The Return of Medicinal Cannabis The Return of Medicinal Cannabis George Kolodner, M.D. DLFAPA FASAM Chief Clinical Officer Clinical Professor of Psychiatry Georgetown University School of Medicine University of Maryland School of Medicine

More information

Medical Cannabis. Christine Yoshioka, NP

Medical Cannabis. Christine Yoshioka, NP Medical Cannabis Christine Yoshioka, NP Objectives Brief history of Cannabis in cultures Review of the Endocanabinoid system Exogenous cannabis Medical research involving cannabis and federal restrictions

More information

Cannabinoids and Mental Health

Cannabinoids and Mental Health Cannabinoids and Mental Health https://upload.wikimedia.org/wikipedia/commons Karen M. Lounsbury, PhD Professor of Pharmacology 802-656-3231, Karen.lounsbury@uvm.edu Objectives Describe the underlying

More information

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine MEDICAL CANNABIS FOR NEUROLOGICAL DISEASES July 15 TH, 2017 ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine GOALS AND OBJECTIVES

More information

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis) Member of the Cannabaceae family of flowering plants (along with hops) sativa (v. sativa, indica, afghanica, ruderalis) Only females flowers contain high concentrations of psychoactive oils (cannabinoids)

More information

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD CECILIA HILLARD, PHD DEPARTMENT OF PHARMACOLOGY NEUROSCIENCE RESEARCH CENTER Disclosures Member of the Scientific Advisory Board

More information

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP Page 1 1. In what year did the possession and transfer of cannabis for recreational use become illegal in the United States? A. 1937 B. 1941 C. 1933 2.

More information

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest

More information

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy The Effects known & unknown of Marijuana in Older Adults Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy Learning Objectives 1. Review various dosing strategies for medical

More information

Cannabis: Therapeutic properties of the plant

Cannabis: Therapeutic properties of the plant Cannabis: Therapeutic properties of the plant Medicinal cannabis is still illegal to be used in South Africa. In a victory for marijuana users across South Africa, ConCourt has officially legalised cannabis

More information

History Of Medical Cannabis

History Of Medical Cannabis History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction

More information

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University sgkinsey@mail.wvu.edu Any opinions expressed are my own and do not reflect any official position of WVU beanpot.co

More information

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests

More information

A look at Marijuana in 2014

A look at Marijuana in 2014 A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5

More information

CANNABIDIOL (CBD) THE BE ALL END ALL?

CANNABIDIOL (CBD) THE BE ALL END ALL? CANNABIDIOL (CBD) THE BE ALL END ALL? John Schaeffer, DO PMG neurology specialists Clinical associate professor Department of neurology University of Washington school of medicine CANNABIS BRIEF HISTORY

More information

(THC) Delta9-tetrahydrocannabinol:

(THC) Delta9-tetrahydrocannabinol: (THC) Delta9-tetrahydrocannabinol: Most prominent compound found in the cannabis plant found in the 1960 s. THC binds to the CB1 and CB2 receptors causing a change in the function of the cell it is binding.

More information

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure. Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center Controversies in Pain Management Conference Johnson City, TN November 13, 2015 Disclosure

More information

Marijuana and cannabinoids

Marijuana and cannabinoids Psych 181: Dr. Anagnostaras Lec 10: Marijuana Marijuana and cannabinoids Cannabis sativa, hemp One of earliest non-food plants cultivated fiber for rope, seeds for oil and birdseed 1st archaeological evidence

More information

History of Medical Cannabis in Nursing

History of Medical Cannabis in Nursing History of Medical Cannabis in Nursing Kristen Luttenberger RN, MSN, CCRN, APNc http://marijuanapolitics.com/wp-content/uploads/2016/07/caduceus-lg.jpg https://images-na.ssl-imagesamazon.com/images/i/41gtt5pb4el._sx314_bo1,204,203,200_.jpg

More information

MPH, MBA, FACPM, FACN

MPH, MBA, FACPM, FACN CBD and the Brain Michael Lewis, MD, MPH, MBA, FACPM, FACN Colonel (Retired), U.S. Army a 501(c)(3) nonprofit organization Temp-A.ppt 9/29/2017 1 IHS February 2018 What do these men have in common? Aiden

More information

Durban Poison (Pure Indica) Hindu Kush (Pure Sativa) Northern Lights (Ruderalis-Indica Hybrid) Royal Dwarf (Ruderalis-Sativa Hybrid) 11 Adapted from Figure 1. The endocannabinoid System in the Nervous

More information

Cannabis and the Endocannabinoid System

Cannabis and the Endocannabinoid System Cannabis and the Endocannabinoid System September 7, 2018 Bangkok, Thailand David Bearman, MD Goleta, California Executive VP, American Academy of Cannabinoid Medicine AACMSITE.org Shen Nung Ping

More information

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015 Medical Marijuana Kent W. Peterson, MD, FACOEM Occupational Health Strategies, Inc. Charlottesville, VA Speaker Disclosure Requirements 1. Do not dispense, prescribe, refer or recommend MMJ 2. Have no

More information

Cannabis in the treatment of Autism:

Cannabis in the treatment of Autism: Cannabis in the treatment of Autism: Are we ready? Deb Karhson, PhD and Lawrence Fung, MD, PhD Cannabis Anecdotal Data: Comparing Epilepsy and Autism+ Science of Cannabinoids: Endocannabinoid System Receptor

More information

Medical Marijuana A Primer for Pharmacists

Medical Marijuana A Primer for Pharmacists Medical Marijuana A Primer for Pharmacists Emory S. Martin, PharmD FASHP Texas Society of Health System Pharmacists Learning Objectives Recognize key components of the endocannabinoid system Identify possible

More information

Cannabis 101 Safe, Versatile & Effective

Cannabis 101 Safe, Versatile & Effective Cannabis 101 Safe, Versatile & Effective Cannabis is a treasure trove of healing. Dr. Raphael Mechoulam, He is the father of cannabis science is an organic chemist and professor of Medical Chemistry, at

More information

CANNABIS FOR THE RHEUMATOLOGIST

CANNABIS FOR THE RHEUMATOLOGIST CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology

More information

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

MEDICAL MARIJUANA: WHAT S THE EVIDENCE? MEDICAL MARIJUANA: WHAT S THE EVIDENCE? L A U R A A. M A R K L E Y, M D B O A R D - C E R T I F I E D I N P E D I A T R I C S / G E N E R A L P S Y C H I A T R Y / C H I L D & A D O L E S C E N T P S Y

More information

Investigational Pharmacy Cannabidiol treatment in Epilepsy

Investigational Pharmacy Cannabidiol treatment in Epilepsy Jon Beck BS Pharm D Coordinator Investigational Pharmacy Disclosure I have no relevant financial relationships with a Commercial Provider Nebraska Medicine Omaha, NE Investigational Pharmacy Cannabidiol

More information

THE COMPLETE CBD GUIDE

THE COMPLETE CBD GUIDE THE COMPLETE CBD GUIDE WHAT IS CBD (CANNABIDIOL)? 2 WHERE DOES CBD COME FROM? 3 HOW DOES CBD WORK IN THE BODY? 4 HOW MUCH CBD DO I TAKE? 5-6 CBD OIL VS. HEMP OIL 7 CBD NOT THC 8 THE BENEFITS OF CBD 9 PETS

More information

MD GUIDE TO USING MEDICAL CANNABIS

MD GUIDE TO USING MEDICAL CANNABIS Natural Remedy MD GUIDE TO USING MEDICAL CANNABIS The leaves and flowers of the Cannabis plant are consumed in several forms: dried flower buds or various types of concentrated, loose, or pressed resin

More information

Conflicts of interest

Conflicts of interest David Casarett MD MA Professor of Medicine Chief of Palliative Care Duke University Conflicts of interest SAB: Curio Wellness, Gram Research, Resolve Digital, Clinicann Senior advisor: Silver Swan Capital

More information

GW Pharmaceuticals plc. Investor Presentation August 2014

GW Pharmaceuticals plc. Investor Presentation August 2014 GW Pharmaceuticals plc Investor Presentation August 2014 Forward Looking Statements and Disclaimer This presentation contains forward-looking statements. Some of the matters discussed concerning our operations

More information

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum Pennsylvania House of Representatives Joint Health and Judiciary Committee Hearing Medical Cannabis - Health Care Forum Tuesday, March 24, 2015 Philadelphia, Pennsylvania Testimony offered by: David J.

More information

Slide 1 Is Marijuana Medicine?

Slide 1 Is Marijuana Medicine? Slide 1 Is Marijuana Medicine? Perspectives, Potentials, & Problems Allan Barger, MSW PRI Research Analyst www.primeforlife.org Slide 2 Presentation Goals Define terms Identify and explain the human endocannabinoid

More information

Psychoactive drugs Drugs which affect mental processes. Legal but restricted (by prescription only)

Psychoactive drugs Drugs which affect mental processes. Legal but restricted (by prescription only) Psychoactive drugs Drugs which affect mental processes mood, perception, memory, state of consciousness May be illegal: Heroin Cocaine Legal: Alcohol nicotine Legal but restricted (by prescription only)

More information

Global Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018

Global Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018 Global Legal Cannabis Market: Size, Trends & Forecasts (2018-2022) September 2018 Global Legal Cannabis Market: Coverage Executive Summary and Scope Introduction/Market Overview Global Market Analysis

More information

Cannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety

Cannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety Cannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety The use of medical marijuana continues to be an emotionally and politically charged issue. Although cannabis oil preparations have been

More information

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial

More information

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Legalized Marijuana: Uses, Misuses & Abuses Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Disclosures Research grants McNeil Consumer Healthcare (Acetaminophen) Rare Disease Therapeutics

More information

Cannabis 101 Safe, Versatile & Effective Medicine

Cannabis 101 Safe, Versatile & Effective Medicine Cannabis 101 Safe, Versatile & Effective Medicine Cannabis is a treasure trove of healing. Dr. Raphael Mechoulam, the father of cannabis science is an organic chemist and professor of Medical Chemistry,

More information

Marijuana for PTSD Among Veterans? Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Veterans Health Administration

Marijuana for PTSD Among Veterans? Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Veterans Health Administration Marijuana for PTSD Among Veterans? Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Veterans Health Administration DISCLOSURES Employed by the Department of Veteran Affairs

More information

Medical Cannabis use in the Older Patient

Medical Cannabis use in the Older Patient Medical Cannabis use in the Older Patient Dr. Amanjot Sidhu Division of Geriatric Medicine McMaster University Audience Poll What is the fastest-growing demographic of cannabis users? a) Ages 14-23 b)

More information

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds

More information

Marijuana. Cannabinoid Reception in the Brain. Levi van Tol 2/16/2015 Cellular Neuroscience

Marijuana. Cannabinoid Reception in the Brain. Levi van Tol 2/16/2015 Cellular Neuroscience Marijuana Cannabinoid Reception in the Brain Levi van Tol 2/16/2015 Cellular Neuroscience van Tol 1 Books, movies, songs, politics, schools, and just about every corner we turn to, marijuana is a hot topic

More information

CBD (Low-THC) Product Description. CBD (Low-THC) Oil Strain Ratio 15:1 CBD:THC Ingredients: Natural CBD (Low-THC) Oil, Non-GMO Safflower Oil

CBD (Low-THC) Product Description. CBD (Low-THC) Oil Strain Ratio 15:1 CBD:THC Ingredients: Natural CBD (Low-THC) Oil, Non-GMO Safflower Oil CBD (Low-THC) THIS INFORMATION IS PROVIDED FOR THE USE OF PHYSICIANS ONLY. THIS INFORMATION IS INTENDED FOR PHYSICIANS TO USE AS A BASIS FOR DETERMINING WHETHER OR NOT TO RECOMMEND MEDICAL CANNABIS TO

More information

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymphoma Setting Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymhoma Setting Disclosure: No endorsement or promotion of marihuana

More information

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid

More information

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil?

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil? OXZGEN FAQ s What is the Endocannabinoid System? Discovered only a few decades ago, the endocannabinoid system (ECS) is one of the most important physiological systems in our body. It consists of a group

More information

Cannabinoids and Epilepsy. Michael Ciliberto, MD University of Iowa Stead Family Department of Pediatrics

Cannabinoids and Epilepsy. Michael Ciliberto, MD University of Iowa Stead Family Department of Pediatrics Cannabinoids and Epilepsy Michael Ciliberto, MD University of Iowa Stead Family Department of Pediatrics Cannabinoids Cannabinoids= terpenophenolic compounds (give a scent) >80 in Cannabis sativa Cannabidiol

More information

Lecture: Medical Marijuana Long term effects and interac ons with common medicines Neuropharamacology of the brain with cannabis

Lecture: Medical Marijuana Long term effects and interac ons with common medicines Neuropharamacology of the brain with cannabis Lecture: Medical Marijuana Long term effects and interac ons with common medicines Neuropharamacology of the brain with cannabis William Morrone, DO Robert Piccinini, DO Endocannabinoids in Disease and

More information

Guidance for the use of. medicinal cannabis. in Australia. Patient information

Guidance for the use of. medicinal cannabis. in Australia. Patient information Guidance for the use of medicinal cannabis in Australia Patient information Version 1, December 2017 Copyright Commonwealth of Australia 2017 This work is copyright. You may reproduce the whole or part

More information

WHAT TO REMEMBER ABOUT CANNABIS HISTORY

WHAT TO REMEMBER ABOUT CANNABIS HISTORY WHAT TO REMEMBER ABOUT CANNABIS HISTORY Evidence of cannabis (CB) use goes back about 12000 yrs. Starting in Central Asia (Now India, Pakistan and Bangladesh). Hemp was used by the Greeks and Chinese in

More information

Cannabinoids (CB): Outline. CB: Epidemiology. CB: Categorization. CB: Pharmacodynamics. Part #1: Cannabinoid (CB) Primer.

Cannabinoids (CB): Outline. CB: Epidemiology. CB: Categorization. CB: Pharmacodynamics. Part #1: Cannabinoid (CB) Primer. Cannabinoids (CB): Outline 1 2 PART #1: CB Primer Epidemiology Categorization: Endogenous vs. exogenous Natural vs. synthetic Pharmacodynamics (PD) Pharmacokinetics (PK) CB receptor system CNS regional

More information

Cannabis for Drug Resistant Epilepsy

Cannabis for Drug Resistant Epilepsy Cannabis for Drug Resistant Epilepsy MILA SORIN, MD PEDIATRIC NEUROLOGY APRIL 20, 2018 Introduction -Although more than 20 prescription anti-epileptic drugs (AEDs) are available, they prove to be ineffective

More information

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will

More information

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will

More information

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology 2 Pamela C. Cartright, MAE, RT (R)(T) Assistant Professor and Program Director Radiation Therapy Program

More information

Medical Marijuana for Pain How Does Cannabis Work on Your Body?

Medical Marijuana for Pain How Does Cannabis Work on Your Body? Medical Marijuana for Pain How Does Cannabis Work on Your Body? Jeremy Spiegel, MD Medical Director - Casco Bay Medical Westbury, Long Island, New York Intro Brief History of Cannabis Physiology of Cannabis

More information

Cannabis & Hemp therapeutic solutions

Cannabis & Hemp therapeutic solutions Cannabis & Hemp therapeutic solutions with Our Cannabis & Hemp quality standards Thanks to their rich characterization and proprietary extraction method, our therapeutic solutions are a reference point

More information

MARIJUANA & THE EFFECTS ON THE BRAIN

MARIJUANA & THE EFFECTS ON THE BRAIN MARIJUANA & THE EFFECTS ON THE BRAIN Sheryl Ryan, MD Professor of Pediatrics Chief, Division of Adolescent Medicine, Penn State Health Hershey Medical Center DISCLOSURES I have no relevant financial relationships

More information

A Primer About Cannabidiol And The Benefits of CBD

A Primer About Cannabidiol And The Benefits of CBD A Primer About Cannabidiol And The Benefits of CBD Scientists are rapidly discovering more and more about the rather amazing abilities of the cannabinoids found in the cannabis plant. Most of them have

More information

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION Susan R Davidson, MD Maternal Fetal Medicine Department of Ob/Gyn St. Mary s Hospital Madison, WI SSM Health I HAVE NO FINANCIAL DISCLOSURES TO REPORT

More information

Budding Therapies: Medical Cannabis and its Uses

Budding Therapies: Medical Cannabis and its Uses Budding Therapies: Medical Cannabis and its Uses MARIAH CADAVOS, PHARMD & VIVIAN NGUYEN, PHARMD PGY1 PHARMACY PRACTICE RESIDENTS FEBRUARY 10, 2019 1 Disclosures & Disclaimer Both presenters have nothing

More information

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into

More information

The Shifting Federal Regulation of Cannabis Products

The Shifting Federal Regulation of Cannabis Products The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW

More information

CBD and Your Health.

CBD and Your Health. CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear

More information

MEDICAL CANNABIS IN MINNESOTA

MEDICAL CANNABIS IN MINNESOTA MEDICAL CANNABIS IN MINNESOTA MINNESOTA ACADEMY OF PHYSICIAN ASSISTANTS MARCH 18, 2016 TOM ARNESON, MD, MPH MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program

More information

Use of Cannabinoids in Medical Practice

Use of Cannabinoids in Medical Practice Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced

More information

Medical Marijuana in the Workforce. What This Is...And What It Isn t

Medical Marijuana in the Workforce. What This Is...And What It Isn t Medical Marijuana in the Workforce Recommendations for the Occupational Physician Robert S. Goldsmith, M.D., M.P.H. June, 2014 What This Is...And What It Isn t IS: Historical context Legal and social context

More information

Marijuana Science Update

Marijuana Science Update Marijuana Science Update Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse ADVANCING ADDICTION SCIENCE NIDA CANNABIS SCIENCE RESEARCH AREAS EPIDEMIOLOGY: National and Local

More information

MARIJUANA AND THE HEART. Katrinka Kip, MD Northern Nevada Heart Conference April 21, 2018

MARIJUANA AND THE HEART. Katrinka Kip, MD Northern Nevada Heart Conference April 21, 2018 MARIJUANA AND THE HEART Katrinka Kip, MD Northern Nevada Heart Conference April 21, 2018 BEANS, BEANS ARE GOOD FOR YOUR HEART.. (The more you eat, the more you.) But what about marijuana? A DAD CALLED..

More information

THE GRASS IS ALWAYS GREENER: TBI AND THE CLINICAL UTILITY OF MEDICAL MARIJUANA

THE GRASS IS ALWAYS GREENER: TBI AND THE CLINICAL UTILITY OF MEDICAL MARIJUANA THE GRASS IS ALWAYS GREENER: TBI AND THE CLINICAL UTILITY OF MEDICAL MARIJUANA JOE TRETTEL, MD, PHD THE CHASE FAMILY MOVEMENT DISORDERS CENTER, HHC GAYLE KLEIN, MD OUTLINE AND OBJECTIVES 1. The Problem:

More information

Marijuana and the Liver. Lauren Myers MMsc, PA-C

Marijuana and the Liver. Lauren Myers MMsc, PA-C Marijuana and the Liver Lauren Myers MMsc, PA-C Disclosures 1. The speaker/planner Lauren Myers, MMSc, PA-C have no relevant financial relationships to disclose. 2. The planners, Atif Zaman, MD, MPH have

More information

PHYTOCANNABINOIDS AND THEIR MEDICINAL APPLICATIONS

PHYTOCANNABINOIDS AND THEIR MEDICINAL APPLICATIONS Toll Free: 1.800.516.1504 info@vitaliset.com vitaliset.com Find us on Instagram! vitalisextractiontech PHYTOCANNABINOIDS AND THEIR MEDICINAL APPLICATIONS A recent history of prejudice against the cannabis

More information

Medical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University

Medical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University Medical Cannabis use in the Older Patient Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University Disclosure Relationships with commercial interests: Grants/Research Support: none Speakers

More information

Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research

Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 TITLE: Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol

More information

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers

More information

Getting Into the Weed: Potentials and Pitfalls Affecting Medical Use

Getting Into the Weed: Potentials and Pitfalls Affecting Medical Use Getting Into the Weed: Potentials and Pitfalls Affecting Medical Use Cydney E. McQueen, PharmD Clinical Associate Professor UMKC School of Pharmacy Objectives Describe in simple terms the endocannabinoid

More information

What s Hot. Thermal Ablation. Slide 1. Slide 2. Slide 3

What s Hot. Thermal Ablation. Slide 1. Slide 2. Slide 3 Slide 1 Hot Topics in the World of Epilepsy Joseph I. Sirven, MD Professor and Chairman Department of Neurology 1 Slide 2 Surgery & Devices for Epilepsy Seizure Emergencies Cannabis What s Hot Slide 3

More information

Medical Cannabis Then and Now. Jeffrey Skell, PhD

Medical Cannabis Then and Now. Jeffrey Skell, PhD Medical Cannabis Then and Now Jeffrey Skell, PhD 2016 Agenda A Brief History of Cannabis Drug Properties Is Cannabis Developable? The Source of All That Trouble Traditional Medicine in the Far East and

More information

Medical Marijuana in Canada, 2014: Panacea or Blowing Smoke. Dr. Paul Daeninck Mr. Brent Zettl

Medical Marijuana in Canada, 2014: Panacea or Blowing Smoke. Dr. Paul Daeninck Mr. Brent Zettl Medical Marijuana in Canada, 2014: Panacea or Blowing Smoke Dr. Paul Daeninck Mr. Brent Zettl Presenter Disclosure Presenter: Brent Zettl Relationships with commercial interests: President and CEO of Prairie

More information

Cannabis. Medical Marijuana: The Science, not the Politic. Alan P. Agins, Ph.D

Cannabis. Medical Marijuana: The Science, not the Politic. Alan P. Agins, Ph.D Objectives: Medical Marijuana: Examining the Science, Not the Politics Alan P. Agins, Ph.D. President: PRN Associates, Ltd Continuing Medical Education Tucson, AZ Upon completion of this learning activity,

More information

Presentation Outline. Learning Objectives 10/5/2016. Medical Marijuana in the Pharmacology of Cannabinoids. 1) Pharmacology of the cannabinoids

Presentation Outline. Learning Objectives 10/5/2016. Medical Marijuana in the Pharmacology of Cannabinoids. 1) Pharmacology of the cannabinoids Medical Marijuana in the Pharmacology of Cannabinoids Jane Ishmael, Ph.D. Associate Professor of Pharmacology Department of Pharmaceutical Sciences College of Pharmacy, Oregon State University Presentation

More information

MEDICAL CANNABIS IN MINNESOTA

MEDICAL CANNABIS IN MINNESOTA MEDICAL CANNABIS IN MINNESOTA EPILEPSY & SEIZURES WELLNESS EXPO APRIL 16, 2016 MICHELLE LARSON, MPA MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program State

More information

Medical Marijuana Myths and Realities

Medical Marijuana Myths and Realities Medical Marijuana Myths and Realities Herbert D. Kleber, M.D. Professor of Psychiatry Director, Division on Substance Abuse Columbia University/NYSPI October 8, 2013 THS 2013 Biarritz Introduction Marijuana

More information

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology

More information

Review of the neurological benefits of phytocannabinoids

Review of the neurological benefits of phytocannabinoids SNI: General Neurosurgery OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: C. David Hunt, M.D. Marquette General Neurosurgery, Brooklyn, NY, USA Review Article

More information

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the

More information

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce Medical marijuana and the impact of marijuana policy on children Karen M. Wilson, MD, MPH, FAAP Associate Professor of Pediatrics Section Head, Pediatric Hospital Medicine University of Colorado School

More information